Medical  care of type 2 diabetes mellitus in light of international and national  recommendations: a retrospective analysis

Konstantin Burgmann; Sandra A. Fatio; Beat Jordi; Jonas Rutishauser

doi:10.4414/smw.2013.13871

Original article

Vol. 143 No. 4344 (2013)

Medical care of type 2 diabetes mellitus in light of international and national recommendations: a retrospective analysis

Konstantin Burgmann
Sandra A. Fatio
Beat Jordi
Jonas Rutishauser

DOI: https://doi.org/10.4414/smw.2013.13871
Cite this as:: Swiss Med Wkly. 2013;143:w13871
Published: 20.10.2013

References

UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–53.
Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–89.
Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, et al. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2006;29(8):1963–72.
Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32(1):193–203.
American Diabetes Association. Executive summary: Standards of medical care in diabetes – 2012. Diabetes Care. 2012;35(Suppl 1):S4–S10.
Philippe J, Brändle M, Carrel J, Diem P, Keller U, Kuntschen F, et al. Massnahmen zur Blutzuckerkontrolle bei Patienten mit Typ-2 Diabetes mellitus. Consensus statement der Schweizerischen Gesellschaft für Endokrinologie und Diabetologie (SGED). Schweiz Med Forum. 2009;9(3):50–5.
Levey AS, Bosch JP, Breyer Lewis J, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Int Med. 1999;130(6):461–70.
American Diabetes Association. Standards of Medical Care in Diabetes – 2009. Diabetes Care. 2009;32(Supplement_1):S13–S61.
Thomann R, Lenherr C, Keller U. Glycaemic control in hospitalised diabetic patients at the University Hospital Basel in 2002 and in 2005. Swiss Med Wkly. 2009;139(37-38):547–52.
Gerber PA, Spirk D, Brändle M, Thoenes M, Lehmann R, Keller U. Regional differences of glycaemic control in patients with type 2 diabetes mellitus in Switzerland: a national cross-sectional survey. Swiss Med Wkly. 2011;141w13218.
Guisasola FÁ, Mavros P, Nocea G, Alemao E, Alexander CM, Yin D. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study. Diabetes, Obesity & Metab 2008;10(Supplement 1):8–15.
Mann E, Vonbank A, Drexel H, Saely C. Diabetes care among older adults in primary care in Austria – a cross-sectional study. Swiss Med Wkly. 2012;142w13646.
American Diabetes Association. Standards of medical care in diabetes – 2012. Diabetes Care. 2012;35(Supplement 1):S11–63.
American Diabetes Association. Standards of Medical Care in Diabetes--2013. Diabetes Care 2013;36(Supplement 1):S11–S66.
Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364–79.
UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854–65.
Gaede P, Lund-Andersen H, Parving H-H, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580–91.
Puder J, Grimm J-J, Hagon-Traub I, Ruiz J, Saner H. DIAFit, ein Schweizer Programm zur Förderung der körperlichen Aktivität bei Patienten mit Diabetes Typ 2. Schweiz Med Forum. 2011;11(27):478–80.
Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129–39.

How to Cite

1.

Burgmann K, Fatio S, Jordi B, Rutishauser J. Medical care of type 2 diabetes mellitus in light of international and national recommendations: a retrospective analysis. Swiss Med Wkly [Internet]. 2013 Oct. 20 [cited 2024 Nov. 8];143(4344):w13871. Available from: https://smw.ch/index.php/smw/article/view/1765

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Most read articles by the same author(s)

Jonas Rutishauser, Statins in clinical medicine , Swiss Medical Weekly: Vol. 141 No. 4748 (2011)
Jonathan Benhamou, Christian Schindler, Jonas Rutishauser, Prevalence of vitamin D deficiency in an inpatient population in the Swiss Canton of Basel-Country , Swiss Medical Weekly: Vol. 151 No. 0910 (2021)
Brigitte Engel, Christian Schindler, Jörg D. Leuppi, Jonas Rutishauser, Predictors of re-exacerbation after an index exacerbation of chronic obstructive pulmonary disease in the REDUCE randomised clinical trial , Swiss Medical Weekly: Vol. 147 No. 1920 (2017)
Jonas Rutishauser, The role of statins in clinical medicine -LDL - cholesterol lowering and beyond , Swiss Medical Weekly: Vol. 136 No. 0304 (2006)
Jonas Rutishauser, To test, or not to test, and how … copeptin, please advise! , Swiss Medical Weekly: Vol. 150 No. 2930 (2020)

[1] UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–53.

[2] Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–89.

[3] Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, et al. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2006;29(8):1963–72.

[4] Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32(1):193–203.

[5] American Diabetes Association. Executive summary: Standards of medical care in diabetes – 2012. Diabetes Care. 2012;35(Suppl 1):S4–S10.

[6] Philippe J, Brändle M, Carrel J, Diem P, Keller U, Kuntschen F, et al. Massnahmen zur Blutzuckerkontrolle bei Patienten mit Typ-2 Diabetes mellitus. Consensus statement der Schweizerischen Gesellschaft für Endokrinologie und Diabetologie (SGED). Schweiz Med Forum. 2009;9(3):50–5.

[7] Levey AS, Bosch JP, Breyer Lewis J, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Int Med. 1999;130(6):461–70.

[8] American Diabetes Association. Standards of Medical Care in Diabetes – 2009. Diabetes Care. 2009;32(Supplement_1):S13–S61.

[9] Thomann R, Lenherr C, Keller U. Glycaemic control in hospitalised diabetic patients at the University Hospital Basel in 2002 and in 2005. Swiss Med Wkly. 2009;139(37-38):547–52.

[10] Gerber PA, Spirk D, Brändle M, Thoenes M, Lehmann R, Keller U. Regional differences of glycaemic control in patients with type 2 diabetes mellitus in Switzerland: a national cross-sectional survey. Swiss Med Wkly. 2011;141w13218.

[11] Guisasola FÁ, Mavros P, Nocea G, Alemao E, Alexander CM, Yin D. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study. Diabetes, Obesity & Metab 2008;10(Supplement 1):8–15.

[12] Mann E, Vonbank A, Drexel H, Saely C. Diabetes care among older adults in primary care in Austria – a cross-sectional study. Swiss Med Wkly. 2012;142w13646.

[13] American Diabetes Association. Standards of medical care in diabetes – 2012. Diabetes Care. 2012;35(Supplement 1):S11–63.

[14] American Diabetes Association. Standards of Medical Care in Diabetes--2013. Diabetes Care 2013;36(Supplement 1):S11–S66.

[15] Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364–79.

[16] UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854–65.

[17] Gaede P, Lund-Andersen H, Parving H-H, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580–91.

[18] Puder J, Grimm J-J, Hagon-Traub I, Ruiz J, Saner H. DIAFit, ein Schweizer Programm zur Förderung der körperlichen Aktivität bei Patienten mit Diabetes Typ 2. Schweiz Med Forum. 2011;11(27):478–80.

[19] Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129–39.